Johnson & Johnson (NYSE: JNJ) Recovers 15.88% From 52-Week Low, Is JNJ Still A High-Risk, High-Reward Play?

Johnson & Johnson (NYSE:JNJ) currently has a daily average trading volume of 6.35M but it saw 7441051 shares traded in last market. With a market cap of 399.26B USD, the company’s current market price of $165.86 came rising about 1.47 while comparing to the previous closing price of $163.45. In past 52 weeks, the stock remained buoying in the range of price level as high as $168.85 and as low as $143.13. In the recent trading on the day, stock has struck highest price mark of $162.48 while lowest mark touched by it was $165.99.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Daiwa Securities which downgraded the stock as “Neutral” in its note to investors issued on July 23, 2024, recommending a price target of between $160 and $150 for it. HSBC Securities issued its recommendations for the stock as it upgraded the price target for the stock is $170.

Over the week, JNJ’s stock price is moving 0.96% up while it is 1.89% when we observe its performance for the past one month. Year-to-date it is 5.82% up and over the past year, the stock is showing an upside performance of 9.56%.

Currently, Johnson & Johnson’s total number of outstanding shares is 2.41B. Company’s return on investment (ROI) stands at 14.23% and return on equity (ROE) at 22.34%. It has a price to earnings ratio (P/E ratio) of 27.42 while having a 15.65 of forward P/E ratio. Stock’s beta reads 0.52. Stock has a price to book (P/B) ratio of 5.58 while price to sale or P/S ratio amounts to 4.55. Its return on asset (ROA) is 8.79% on average.